Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2020-01-01
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
NCT05403216
Serum Cortisol Levels in Patients With Anxiety and Depression With Symptomatic Oral Lichen Planus
NCT03011658
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
NCT01931293
Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.
NCT06078579
Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study
NCT02332486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral lichen planus
Female patients of the Department of Oral Medicine with oral lichen planus
determination of thyroid hormones and antibodies
TSH, fT3, fT4, anti-TPO and anti-Tg were determined from blood sample
Control
Female patients of the Department of Oral Medicine without oral lichen planus or other immune disorders
determination of thyroid hormones and antibodies
TSH, fT3, fT4, anti-TPO and anti-Tg were determined from blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
determination of thyroid hormones and antibodies
TSH, fT3, fT4, anti-TPO and anti-Tg were determined from blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for control group: female patients of the Department of Oral Medicine School of Dental Medicine University of Zagreb, without oral lichen planus or other immune disorders; age matched to test group
Exclusion Criteria
35 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zagreb
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Božana Lončar Brzak
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dental Medicine, University of Zagreb
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01122019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.